Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 265 to 270 of 270 entries
Sorted by: Best Match Show Resources per page
Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis.

Dysphagia

Barzegar M, Mirmosayeb O, Rezaei M, Bjørklund G, Nehzat N, Afshari-Safavi A, Shaygannejad V.
PMID: 33580368
Dysphagia. 2021 Feb 12; doi: 10.1007/s00455-021-10245-z. Epub 2021 Feb 12.

Dysphagia is one of the most common symptoms in multiple sclerosis (MS) patients. It can reduce the quality of life and increase the risk of mortality by developing complications such as aspiration pneumonia. The present study was conducted to...

Cite
Barzegar M, Mirmosayeb O, Rezaei M, et al. Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. 2021;doi: 10.1007/s00455-021-10245-z.
Barzegar, M., Mirmosayeb, O., Rezaei, M., Bjørklund, G., Nehzat, N., Afshari-Safavi, A., & Shaygannejad, V. (2021). Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia, . https://doi.org/10.1007/s00455-021-10245-z
Barzegar, Mahdi, et al. "Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis." Dysphagia vol. (2021). doi: https://doi.org/10.1007/s00455-021-10245-z
Barzegar M, Mirmosayeb O, Rezaei M, Bjørklund G, Nehzat N, Afshari-Safavi A, Shaygannejad V. Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. 2021 Feb 12; doi: 10.1007/s00455-021-10245-z. Epub 2021 Feb 12. PMID: 33580368.
Copy Download .nbib Format: NLM
Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics.

Anti-cancer agents in medicinal chemistry

Ghasemali S, Farajnia S, Barzegar A, Rahmati-Yamchi M, Negahdari B, Rahbarnia L, Yousefi-Nodeh H.
PMID: 34792006
Anticancer Agents Med Chem. 2021 Nov 17; doi: 10.2174/1871520621666211118104051. Epub 2021 Nov 17.

BACKGROUND: Angiogenesis is a critical physiological process that plays a key role in tumor progression, metastatic dissemination, and invasion. In the last two decades, the vascular endothelial growth factor (VEGF) signaling pathway has been the area of extensive researches....

Cite
Ghasemali S, Farajnia S, Barzegar A, et al. Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics. Anticancer Agents Med Chem. 2021;doi: 10.2174/1871520621666211118104051.
Ghasemali, S., Farajnia, S., Barzegar, A., Rahmati-Yamchi, M., Negahdari, B., Rahbarnia, L., & Yousefi-Nodeh, H. (2021). Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics. Anti-cancer agents in medicinal chemistry, . https://doi.org/10.2174/1871520621666211118104051
Ghasemali, Samaneh, et al. "Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics." Anti-cancer agents in medicinal chemistry vol. (2021). doi: https://doi.org/10.2174/1871520621666211118104051
Ghasemali S, Farajnia S, Barzegar A, Rahmati-Yamchi M, Negahdari B, Rahbarnia L, Yousefi-Nodeh H. Rational Design of Anti-Angiogenic Peptides to Inhibit VEGF/VEGFR2 Interactions for Cancer Therapeutics. Anticancer Agents Med Chem. 2021 Nov 17; doi: 10.2174/1871520621666211118104051. Epub 2021 Nov 17. PMID: 34792006.
Copy Download .nbib Format: NLM
Corrigendum to ' Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study' [Multiple Sclerosis and Related Disorders Volume 47 (2021) 1-8/ 102625].

Multiple sclerosis and related disorders

Ashtari F, Ataei A, Kafieh R, Khodabandeh Z, Barzegar M, Raei M, Dehghani A, Mansurian M.
PMID: 34217997
Mult Scler Relat Disord. 2021 Sep;54:103116. doi: 10.1016/j.msard.2021.103116. Epub 2021 Jul 01.

No abstract available.

Cite
Ashtari F, Ataei A, Kafieh R, et al. Corrigendum to ' Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study' [Multiple Sclerosis and Related Disorders Volume 47 (2021) 1-8/ 102625]. Mult Scler Relat Disord. 2021;54:103116doi: 10.1016/j.msard.2021.103116.
Ashtari, F., Ataei, A., Kafieh, R., Khodabandeh, Z., Barzegar, M., Raei, M., Dehghani, A., & Mansurian, M. (2021). Corrigendum to ' Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study' [Multiple Sclerosis and Related Disorders Volume 47 (2021) 1-8/ 102625]. Multiple sclerosis and related disorders, 54103116. https://doi.org/10.1016/j.msard.2021.103116
Ashtari, Fereshteh, et al. "Corrigendum to ' Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study' [Multiple Sclerosis and Related Disorders Volume 47 (2021) 1-8/ 102625]." Multiple sclerosis and related disorders vol. 54 (2021): 103116. doi: https://doi.org/10.1016/j.msard.2021.103116
Ashtari F, Ataei A, Kafieh R, Khodabandeh Z, Barzegar M, Raei M, Dehghani A, Mansurian M. Corrigendum to ' Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study' [Multiple Sclerosis and Related Disorders Volume 47 (2021) 1-8/ 102625]. Mult Scler Relat Disord. 2021 Sep;54:103116. doi: 10.1016/j.msard.2021.103116. Epub 2021 Jul 01. PMID: 34217997.
Copy Download .nbib Format: NLM
Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis.

Health science reports

Navari Y, Bagheri AB, Akhavan Rezayat A, SeyedAlinaghi S, Najafi S, Barzegary A, Asadollahi-Amin A.
PMID: 34761124
Health Sci Rep. 2021 Nov 04;4(4):e427. doi: 10.1002/hsr2.427. eCollection 2021 Dec.

BACKGROUND AND AIMS: The kidney transplant patients who receive immunosuppressive and specific medication may lead to different mortality risk factors between kidney transplant patients with COVID-19 and the general population. We aimed to provide a model predictor and a...

Cite
Navari Y, Bagheri AB, Akhavan Rezayat A, et al. Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis. Health Sci Rep. 2021;4(4):e427doi: 10.1002/hsr2.427.
Navari, Y., Bagheri, A. B., Akhavan Rezayat, A., SeyedAlinaghi, S., Najafi, S., Barzegary, A., & Asadollahi-Amin, A. (2021). Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis. Health science reports, 4(4), e427. https://doi.org/10.1002/hsr2.427
Navari, Yasaman, et al. "Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis." Health science reports vol. 4,4 (2021): e427. doi: https://doi.org/10.1002/hsr2.427
Navari Y, Bagheri AB, Akhavan Rezayat A, SeyedAlinaghi S, Najafi S, Barzegary A, Asadollahi-Amin A. Mortality risk factors in kidney-transplanted patients with COVID-19: A systematic review and regression analysis. Health Sci Rep. 2021 Nov 04;4(4):e427. doi: 10.1002/hsr2.427. eCollection 2021 Dec. PMID: 34761124; PMCID: PMC8567748.
Copy Download .nbib Format: NLM
Mask Wearing Hesitancy During the COVID-19 Pandemic in South Iran.

Disaster medicine and public health preparedness

Asadi-Pooya AA, Nezafat A, Sadeghian S, Shahisavandi M, Nabavizadeh SA, Barzegar Z.
PMID: 33750513
Disaster Med Public Health Prep. 2021 Mar 10;1-3. doi: 10.1017/dmp.2021.72. Epub 2021 Mar 10.

PURPOSE: The aim of the current study was to investigate the prevalence of face mask wearing among different groups of people in south Iran. We also investigated the associations between mask wearing hesitancy and various factors.METHODS: We surveyed a...

Cite
Asadi-Pooya AA, Nezafat A, Sadeghian S, et al. Mask Wearing Hesitancy During the COVID-19 Pandemic in South Iran. Disaster Med Public Health Prep. 2021;1-3doi: 10.1017/dmp.2021.72.
Asadi-Pooya, A. A., Nezafat, A., Sadeghian, S., Shahisavandi, M., Nabavizadeh, S. A., & Barzegar, Z. (2021). Mask Wearing Hesitancy During the COVID-19 Pandemic in South Iran. Disaster medicine and public health preparedness, 1-3. https://doi.org/10.1017/dmp.2021.72
Asadi-Pooya, Ali A, et al. "Mask Wearing Hesitancy During the COVID-19 Pandemic in South Iran." Disaster medicine and public health preparedness vol. (2021): 1-3. doi: https://doi.org/10.1017/dmp.2021.72
Asadi-Pooya AA, Nezafat A, Sadeghian S, Shahisavandi M, Nabavizadeh SA, Barzegar Z. Mask Wearing Hesitancy During the COVID-19 Pandemic in South Iran. Disaster Med Public Health Prep. 2021 Mar 10;1-3. doi: 10.1017/dmp.2021.72. Epub 2021 Mar 10. PMID: 33750513; PMCID: PMC8129672.
Copy Download .nbib Format: NLM
On the fabrication of crystalline C60 nanorod transistors from solution.

Nanotechnology

Larsen C, Barzegar HR, Nitze F, Wågberg T, Edman L.
PMID: 22885636
Nanotechnology. 2012 Aug 31;23(34):344015. doi: 10.1088/0957-4484/23/34/344015. Epub 2012 Aug 10.

Flexible and high-aspect-ratio C(60) nanorods are synthesized using a liquid-liquid interfacial precipitation process. As-grown nanorods are shown to exhibit a hexagonal close-packed single-crystal structure, with m-dichlorobenzene solvent molecules incorporated into the crystalline structure in a C(60):m-dichlorobenzene ratio of 3:2....

Cite
Larsen C, Barzegar HR, Nitze F, et al. On the fabrication of crystalline C60 nanorod transistors from solution. Nanotechnology. 2012;23(34):344015doi: 10.1088/0957-4484/23/34/344015.
Larsen, C., Barzegar, H. R., Nitze, F., Wågberg, T., & Edman, L. (2012). On the fabrication of crystalline C60 nanorod transistors from solution. Nanotechnology, 23(34), 344015. https://doi.org/10.1088/0957-4484/23/34/344015
Larsen, Christian, et al. "On the fabrication of crystalline C60 nanorod transistors from solution." Nanotechnology vol. 23,34 (2012): 344015. doi: https://doi.org/10.1088/0957-4484/23/34/344015
Larsen C, Barzegar HR, Nitze F, Wågberg T, Edman L. On the fabrication of crystalline C60 nanorod transistors from solution. Nanotechnology. 2012 Aug 31;23(34):344015. doi: 10.1088/0957-4484/23/34/344015. Epub 2012 Aug 10. PMID: 22885636.
Copy Download .nbib Format: NLM
Showing 265 to 270 of 270 entries